FDA Approves Tremfya (Guselkumab) for Adult Patients with Psoriatic Arthritis
Biosimilar Prescribing Habits in the VA & Academic Settings
Biosimilars Are Slowly Climbing Toward Acceptance in Rheumatology
U.S. Insurers Often Limit Biosimilar Coverage
Rheumatology Biologic Expertise Valued for COVID-19 Treatment Decisions
Rheumatoid Arthritis Therapy Update: What’s Changed & What’s the Same
Pediatric Cases Require Special Considerations & Aggressive Treatment Plans
Clinicians Discuss Current & Future Rheumatoid Arthritis Approaches
FDA Update: New Drug Approvals, New & Expanded Indications, & More
- 1
- 2
- 3
- …
- 32
- Next Page »